Algemeen Ziekenhuis Delta

Roeselare, West-Vlaanderen 8800

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Liver, NASH, Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling